Internal Medicine, Hematology & Oncology · Makawao, HI
NPI
1558562371
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
40 Kupaoa St Unit B-204
Makawao, HI, 96768
Phone (808) 500-3439
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
1,279 services
Medicare patients, 2024
233
Average age 74
Drug cost, 2024
$3.4M
1,694 prescriptions
Company payments, 2025
$3,023
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cecilia Choi was code 99214 (office e&m - established), 652 times for 184 patients. In total Cecilia Choi billed 1,279 services in 9 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 652 | 184 | $100.81 | $66K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 251 | 47 | $13.10 | $3,288 |
| 99215 Office E&M - Established | Office | 197 | 80 | $142.28 | $28K |
| 99205 Office E&M - New | Office | 128 | 128 | $168.25 | $22K |
| 99211 Office E&M - Established | Office | 17 | 15 | $19.34 | $329 |
By year: 2022 $33K for 435 services; 2023 $43K for 383 services; 2024 $121K for 1,279 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cecilia Choi prescribed most often to Medicare patients was Letrozole, with 109 prescriptions and refills. In total Cecilia Choi wrote 1,694 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 109 | 249 | 31 | $2,135 |
| Sodium Chloride 0.9 % Sodium Chloride | 102 | 106 | 27 | $447 |
| Oxycodone Hcl Generic | 87 | 87 | 28 | $1,029 |
| Keytruda Pembrolizumab | 78 | 82 | 14 | $997K |
| Anastrozole Generic | 70 | 158 | 24 | $3,144 |
| Orgovyx Relugolix | 54 | 54 | 11 | $143K |
| Xgeva Denosumab | 51 | 51 | Under 11 | $163K |
| Prednisone Generic | 45 | 48 | 17 | $209 |
| Ondansetron Hcl Generic | 43 | 43 | 27 | $504 |
| Morphine Sulfate Er Morphine Sulfate | 38 | 38 | Under 11 | $893 |
| Prolia Denosumab | 34 | 204 | 23 | $59K |
| Creon Lipase/Protease/Amylase | 31 | 42 | Under 11 | $11K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 28 | 28 | 21 | $377 |
| Olanzapine Generic | 26 | 61 | 13 | $365 |
| Ondansetron Odt Ondansetron | 26 | 26 | 15 | $300 |
Brand drugs: 557 claims; generic drugs: 1,137 claims; opioid claims: 196.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cecilia Choi $3,023 ($3,023 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,279.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 21 | $1,279 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $286 |
| Caris MPI, Inc. | 3 | $228 |
| Pfizer Inc. PFE | 4 | $216 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $182 |
| BeOne Medicines USA, Inc. ONC | 1 | $103 |
| Seagen Inc. PFE | 1 | $99 |
| Tempus AI, Inc TEM | 4 | $92.26 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $58.79 |
| Janssen Biotech, Inc. JNJ | 2 | $54.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.